Intellia Therapeutics CEO John M. Leonard reports sale of $107,910 in common shares

NTLA•2026-11-03

Intellia Therapeutics President and CEO John M. Leonard sold 9,000 shares at $11.99 each on Nov. 2, 2026, for $107,910. He held 1,138,064 shares directly and 58,415 shares through a trust after the sale.

1. Share sale

John M. Leonard sold 9,000 Intellia Therapeutics common shares at $11.99 each on Nov. 2, 2026. After the sale, he held 1,138,064 shares directly and another 58,415 shares through a trust.

Sources

Intellia Therapeutics CEO John M. Leonard reports sale of $107,910 in common shares

Sec

Intellia Therapeutics CEO John M. Leonard reports sale of $107,910 in common shares

1. Share sale

Related News

MEC forecasts 2026 revenue of $630 million to $640 million

LATAM Brasil expects slower growth as fuel, currency weigh on expansion

Astec Industries grants director William Waltz 1,759 RSUs under equity incentive plan

Sources

Intellia Therapeutics CEO John M. Leonard reports sale of $107,910 in common shares

Tronox declares quarterly dividend of $0.05 per share

Booz Allen Hamilton grants controller Dennis Metzfield 122 restricted stock units